Atria Investments Inc Purchases 5,066 Shares of Nutrien Ltd. $NTR

Atria Investments Inc grew its position in shares of Nutrien Ltd. (NYSE:NTRFree Report) by 32.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 20,816 shares of the company’s stock after purchasing an additional 5,066 shares during the period. Atria Investments Inc’s holdings in Nutrien were worth $1,212,000 at the end of the most recent reporting period.

Several other institutional investors have also recently modified their holdings of the company. JPMorgan Chase & Co. raised its holdings in shares of Nutrien by 48.7% during the 1st quarter. JPMorgan Chase & Co. now owns 6,992,535 shares of the company’s stock valued at $347,319,000 after buying an additional 2,291,518 shares in the last quarter. Vanguard Group Inc. raised its stake in shares of Nutrien by 7.1% during the first quarter. Vanguard Group Inc. now owns 21,191,003 shares of the company’s stock worth $1,051,709,000 after acquiring an additional 1,412,503 shares in the last quarter. Canada Pension Plan Investment Board lifted its holdings in shares of Nutrien by 17.1% in the 1st quarter. Canada Pension Plan Investment Board now owns 8,786,309 shares of the company’s stock worth $436,137,000 after acquiring an additional 1,284,181 shares during the last quarter. Nuveen LLC purchased a new stake in shares of Nutrien in the 1st quarter valued at $63,542,000. Finally, The Manufacturers Life Insurance Company boosted its stake in shares of Nutrien by 16.5% in the 1st quarter. The Manufacturers Life Insurance Company now owns 6,554,638 shares of the company’s stock valued at $326,927,000 after purchasing an additional 927,041 shares in the last quarter. 63.10% of the stock is currently owned by institutional investors.

Nutrien Stock Up 3.0%

NYSE NTR opened at $55.63 on Friday. Nutrien Ltd. has a 1 year low of $43.69 and a 1 year high of $65.08. The stock has a market capitalization of $26.95 billion, a PE ratio of 19.94, a PEG ratio of 0.92 and a beta of 0.83. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.33 and a quick ratio of 0.85. The business’s 50-day moving average is $57.40 and its 200 day moving average is $58.17.

Nutrien (NYSE:NTRGet Free Report) last released its quarterly earnings results on Wednesday, November 5th. The company reported $0.97 EPS for the quarter, beating analysts’ consensus estimates of $0.91 by $0.06. The business had revenue of $5.82 billion during the quarter, compared to analyst estimates of $5.59 billion. Nutrien had a return on equity of 6.51% and a net margin of 5.25%.Nutrien’s quarterly revenue was up 12.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.39 EPS. Sell-side analysts forecast that Nutrien Ltd. will post 3.72 earnings per share for the current year.

Nutrien Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 16th. Investors of record on Wednesday, December 31st will be issued a $0.545 dividend. The ex-dividend date is Wednesday, December 31st. This represents a $2.18 annualized dividend and a yield of 3.9%. Nutrien’s payout ratio is 58.76%.

Wall Street Analysts Forecast Growth

NTR has been the topic of a number of analyst reports. Wall Street Zen cut shares of Nutrien from a “strong-buy” rating to a “buy” rating in a research report on Friday, September 5th. National Bankshares started coverage on Nutrien in a report on Friday, September 5th. They issued a “sector perform” rating and a $64.00 price objective on the stock. Weiss Ratings restated a “hold (c)” rating on shares of Nutrien in a report on Wednesday, October 8th. Zacks Research lowered Nutrien from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 16th. Finally, Wells Fargo & Company reiterated a “cautious” rating on shares of Nutrien in a research report on Thursday, October 16th. One analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, fourteen have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Nutrien currently has a consensus rating of “Hold” and an average price target of $62.83.

Read Our Latest Analysis on NTR

About Nutrien

(Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Recommended Stories

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTRFree Report).

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.